Orgenesis Inc. Common Stock
ORGS
ORGS was delisted on the 18th of October, 2024.
33 hedge funds and large institutions have $11.1M invested in Orgenesis Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 15 reducing their positions, and 15 closing their positions.
7.27% less ownership
Funds ownership: 16.22% → 8.95% (-7.3%)
15% less funds holding
Funds holding: 39 → 33 (-6)
40% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 15
51% less capital invested
Capital invested by funds: $22.5M → $11.1M (-$11.4M)
60% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 15
99% less call options, than puts
Call options by funds: $4K | Put options by funds: $463K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$601K |
| 2 |
E
Ergoteles
New York
|
+$374K |
| 3 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
+$322K |
| 4 |
SG Americas Securities
New York
|
+$322K |
| 5 |
HF
HRT Financial
New York
|
+$279K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$4.57M |
| 2 |
State Street
Boston,
Massachusetts
|
-$1.02M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$876K |
| 4 |
Renaissance Technologies
New York
|
-$797K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$761K |
ORGS Hedge Fund Activity: Q2 2021 in Review
33 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Orgenesis Inc. Common Stock (ORGS) for Q2 2021, worth a combined $11.1M — down 51% from $22.5M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of ORGS and 9 opened new positions — a net loss of 6 holders — while 15 trimmed existing stakes and 6 added.
The largest buyer was Millennium Management, adding an estimated $601K. The largest seller was BlackRock, cutting an estimated $4.57M.
- 33 institutional investors held Orgenesis Inc. Common Stock (ORGS) as of Q2 2021, down from 39 in Q1 2021.
- Funds reported $11.1M of Orgenesis Inc. Common Stock stock for Q2 2021, down 51% quarter-over-quarter.
- 9 funds opened new Orgenesis Inc. Common Stock positions in Q2 2021 and 15 closed out, a net change of -6 holders.
- The largest Orgenesis Inc. Common Stock buyer in Q2 2021 was Millennium Management, an estimated $601K added.
- The largest Orgenesis Inc. Common Stock seller in Q2 2021 was BlackRock, an estimated $4.57M sold.
Based on aggregated 13F filings for Q2 2021.